Human movement company Scientific Analytics Inc reported on Wednesday the receipt of the US FDA's 510K medical device designation for its computer-vision-powered motion health analysis technology, DARI Health.
According to the company, its markerless DARI Motion computer vision and biomechanical analysis technology has been refined by more than 425bn data points of human motion gathered across applications in wellness, military, elite athletics and healthcare. It helps people and organisations to improve performance, avoid injury and reduce unnecessary costs.
Scientific Analytics has also formed a strategic collaboration with Hospital for Special Surgery (HSS), the world's largest academic musculoskeletal health company.
The newly formed partnership will integrate leading knowledge and technology with the aim of setting new standards for full-body, dynamic motion analysis at population scale. It will provide the first medical device that will arm clinicians with an FDA-cleared, accurate and reliable solution that easily and seamlessly captures clinically-relevant human movement data at the point of care.
Through the partnership, the companies aim to create a new standard in data-driven, value-based musculoskeletal health while objectively documenting outcomes and delivering an engaging patient experience.
Saluda Medical secures CE certification for EVA Sensing Technology in Europe
Antin to acquire clinical trial equipment provider Emsere
Hyphens Pharma licenses Cerapro skin cream to Louis Widmer for six European markets
Profusa signs French distributor to expand Lumee Oxygen rollout in Europe
Sensiva Health names new chief operating officer
BrioHealth Solutions enrols 100th participant in BrioVAD System trial
Abbott's Amplatzer Piccolo Delivery System receives US FDA clearance and CE Mark
Amphix Bio announces initial closing of USD12.5m seed financing round
Bioretec wins FDA breakthrough status for biodegradable orthopaedic DrillPin
Amferia raises EUR3.5m to advance antimicrobial wound-care platform
BioCryst wins FDA approval for oral HAE prophylaxis in young children
ALR Technologies announces GluCurve Pet CGM relaunch in Canada
Galderma secures EU MDR certification for Sculptra, expanding use to multiple body areas
Clinical Laserthermia Systems applies for CE marking of ClearPoint Prism neuro laser system